Clinical impact of ¹⁸F-FDG-PET among memory clinic patients with uncertain diagnosis.

Flutemetamol PET was positive in 5 out of 6 patients finally diagnosed with AD, in 1 out of 3 patients finally diagnosed with FTLD and in none of the cases finally diagnosed with “other dementia.” Incremental diagnostic value of FDG-PET Among patients diagnosed with dementia at baseline, the accuracy of the clinical diagnosis with respect to the final diagnosis at follow-up increased from the pre- to the post-FDG-PET diagnosis: from 77 to 90% in patients with AD and from 85 to 94% in patients with FTLD ( p < 0.01, McNemar test) and improved with a trend toward significance in patients with DLB (Table 3 ).

also in 3,729 other papers